Clinical Trials Directory

Trials / Unknown

UnknownNCT05749692

The Impact of COVID-19 Infection on the Symptoms of Functional Dyspepsia

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Although respiratory symptoms were predominant in patients infected with COVID-19, gastrointestinal symptoms were always reported in about 10% patients. Previous studies demonstrated that the SARS-CoV-2 virus still persists in stool samples for a long time after initial infection. Moreover, some patients had a longer duration of COVID-19-related gastrointestinal symptoms, which was defined as "post-acute COVID-19 syndrome". Previous studies have shown that functional gastrointestinal disorders may occur after acute gastroenteritis. Functional dyspepsia (FD) is one of the most common functional gastrointestinal disorders. FD was reported to be correlated with multiple pathophysiological mechanisms, including GI bacterial imbalance, disordered gut microbiota, and disturbed barrier and immune function. It is unknown whether COVID-19 infection could exacerbate the symptoms of FD. Therefore, we followed up a group of FD patients before and after COVID-19 and investigate the impact of COVID-19 infection on the symptoms of FD.

Conditions

Timeline

Start date
2022-12-01
Primary completion
2023-08-01
Completion
2023-08-01
First posted
2023-03-01
Last updated
2023-03-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05749692. Inclusion in this directory is not an endorsement.